Napo Pharm.Regs Share Discussion Threads

[mavverick] 25/9/2008 11:37

finally! market agrees !

[mavverick] 24/9/2008 09:57

RNS positive!!

[double6] 05/9/2008 20:13

Back down to where this thread started from!

[groats118] 13/8/2008 14:59

MONIS,

You still here, very dissapointing performance from my original purchase! Unlikely I will ever get that back!!

[monis] 25/6/2008 16:56

groats - I also bought a few more a couple of weeks ago.

[groats118] 25/6/2008 16:42

Nice, tick up before close. Very interesting!

U got a target price for these?

[groats118] 25/6/2008 16:14

That 30k is a buy :)-

Monis, how long you been in these?

[monis] 25/6/2008 14:39

Perhaps they were sells but have immediately found a new home via a market maker thus no fall nor rise ie those buys we can see have been bought from the 200,000 seller. Still positive.

[monis] 25/6/2008 14:27

groats - what do you think now...

[monis] 25/6/2008 14:18

I don't know they are buys, I said trades not buys. They do seem strange but if they are sells why no drop in price? I don't know how to interpret them.

The 75,000 looks like a buy though.

[groats118] 25/6/2008 14:12

MONIS

How do you know they are buys? I bought £1200 worth a couple of days back and had to pay full offer price, I can't see how they getting mid-price for that quantity. I would say they are sells

[monis] 25/6/2008 13:52

make that three...

[monis] 25/6/2008 13:51

two big trades today.

[monis] 24/6/2008 16:47

25,000 buy at the end of the day by the look of things.

[monis] 23/6/2008 15:13

few buys as thought.


groats- I think it's good news, dyor of cause.

[groats118] 23/6/2008 13:50

MONIS

Are you the only shareholder in these???

How will America take this news iyo?

[monis] 23/6/2008 11:59

Would expect to see more buying from the states this afternoon.

[monis] 23/6/2008 10:43

Napo Pharma raises $2.1 mln net from convertible debt and share issues

LONDON (Thomson Financial) - Napo Pharmaceuticals Inc. said it has raised
around $2.1 million gross through the issue of convertible debt and shares.
The company also said it has now progressed commercial license talks with at
least two potential partners for its crofelemer diarrhoea treatment.
"We are pleased to announce this fundraising and the financial strength it
provides Napo to complete our corporate licensing discussions while continuing
with the progress of our final Phase 3 clinical trial for CRO-HIV and all NDA
related activities," chief executive Lisa Conte said.
[e-mail]
bsu/slm

[monis] 23/6/2008 10:29

From RNS


----------
The directors are confident that the Company will be able to secure a partnership for the commercial rights to crofelemer which will provide sufficient resources to the Company to fund the development of CRO-HIV through to FDA approval.

The Company has now progressed commercial license discussions with at least two potential partners, with customary commercial pharmaceutical license provisions including development costs, milestones, and royalty payments. Any license agreement will be subject to mutual diligence and a definitive agreement.


------------


DYOR

[monis] 23/6/2008 10:17

RNS out - excellent news re funding and discussions for potential partnerships imo.

[monis] 19/6/2008 16:32

another buy reported on the bell.

[monis] 19/6/2008 16:12

Looks like a few more delayed buys are going to come through.